These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23294830)

  • 1. Discovery of INT131: a selective PPARγ modulator that enhances insulin sensitivity.
    Taygerly JP; McGee LR; Rubenstein SM; Houze JB; Cushing TD; Li Y; Motani A; Chen JL; Frankmoelle W; Ye G; Learned MR; Jaen J; Miao S; Timmermans PB; Thoolen M; Kearney P; Flygare J; Beckmann H; Weiszmann J; Lindstrom M; Walker N; Liu J; Biermann D; Wang Z; Hagiwara A; Iida T; Aramaki H; Kitao Y; Shinkai H; Furukawa N; Nishiu J; Nakamura M
    Bioorg Med Chem; 2013 Feb; 21(4):979-92. PubMed ID: 23294830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INT131: a selective modulator of PPAR gamma.
    Motani A; Wang Z; Weiszmann J; McGee LR; Lee G; Liu Q; Staunton J; Fang Z; Fuentes H; Lindstrom M; Liu J; Biermann DH; Jaen J; Walker NP; Learned RM; Chen JL; Li Y
    J Mol Biol; 2009 Mar; 386(5):1301-11. PubMed ID: 19452630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of N-(5-chloro-6-(quinolin-3-yloxy)pyridin-3-yl)benzenesulfonamide derivatives as non-TZD peroxisome proliferator-activated receptor γ (PPARγ) agonist.
    Bajare S; Anthony J; Nair A; Marita R; Damre A; Patel D; Rao C; Sivaramakrishnan H; Deka N
    Eur J Med Chem; 2012 Dec; 58():355-60. PubMed ID: 23142675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INT-131, a PPARgamma agonist for the treatment of type 2 diabetes.
    Kintscher U; Goebel M
    Curr Opin Investig Drugs; 2009 Apr; 10(4):381-7. PubMed ID: 19337960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel transcriptome profiling analyses demonstrate that selective peroxisome proliferator-activated receptor γ (PPARγ) modulators display attenuated and selective gene regulatory activity in comparison with PPARγ full agonists.
    Tan Y; Muise ES; Dai H; Raubertas R; Wong KK; Thompson GM; Wood HB; Meinke PT; Lum PY; Thompson JR; Berger JP
    Mol Pharmacol; 2012 Jul; 82(1):68-79. PubMed ID: 22496518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzimidazolones: a new class of selective peroxisome proliferator-activated receptor γ (PPARγ) modulators.
    Liu W; Lau F; Liu K; Wood HB; Zhou G; Chen Y; Li Y; Akiyama TE; Castriota G; Einstein M; Wang C; McCann ME; Doebber TW; Wu M; Chang CH; McNamara L; McKeever B; Mosley RT; Berger JP; Meinke PT
    J Med Chem; 2011 Dec; 54(24):8541-54. PubMed ID: 22070604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) γ/δ agonists with high potency and in vivo efficacy.
    Keil S; Matter H; Schönafinger K; Glien M; Mathieu M; Marquette JP; Michot N; Haag-Diergarten S; Urmann M; Wendler W
    ChemMedChem; 2011 Apr; 6(4):633-53. PubMed ID: 21400663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetes.
    Leibowitz MD; Ardecky RJ; Boehm MF; Broderick CL; Carfagna MA; Crombie DL; D'Arrigo J; Etgen GJ; Faul MM; Grese TA; Havel H; Hein NI; Heyman RA; Jolley D; Klausing K; Liu S; Mais DE; Mapes CM; Marschke KB; Michellys PY; Montrose-Rafizadeh C; Ogilvie KM; Pascual B; Rungta D; Tyhonas JS; Urcan MS; Wardlow M; Yumibe N; Reifel-Miller A
    Endocrinology; 2006 Feb; 147(2):1044-53. PubMed ID: 16269450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new class of non-thiazolidinedione, non-carboxylic-acid-based highly selective peroxisome proliferator-activated receptor (PPAR) γ agonists: design and synthesis of benzylpyrazole acylsulfonamides.
    Rikimaru K; Wakabayashi T; Abe H; Imoto H; Maekawa T; Ujikawa O; Murase K; Matsuo T; Matsumoto M; Nomura C; Tsuge H; Arimura N; Kawakami K; Sakamoto J; Funami M; Mol CD; Snell GP; Bragstad KA; Sang BC; Dougan DR; Tanaka T; Katayama N; Horiguchi Y; Momose Y
    Bioorg Med Chem; 2012 Jan; 20(2):714-33. PubMed ID: 22209730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-Activity Relationship of 2,4-Dichloro-N-(3,5-dichloro-4-(quinolin-3-yloxy)phenyl)benzenesulfonamide (INT131) Analogs for PPARγ-Targeted Antidiabetics.
    Frkic RL; He Y; Rodriguez BB; Chang MR; Kuruvilla D; Ciesla A; Abell AD; Kamenecka TM; Griffin PR; Bruning JB
    J Med Chem; 2017 Jun; 60(11):4584-4593. PubMed ID: 28485590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
    Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective modulation of PPARγ activity can lower plasma glucose without typical thiazolidinedione side-effects in patients with Type 2 diabetes.
    Dunn FL; Higgins LS; Fredrickson J; DePaoli AM;
    J Diabetes Complications; 2011; 25(3):151-8. PubMed ID: 20739195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective PPARγ modulator INT131 normalizes insulin signaling defects and improves bone mass in diet-induced obese mice.
    Lee DH; Huang H; Choi K; Mantzoros C; Kim YB
    Am J Physiol Endocrinol Metab; 2012 Mar; 302(5):E552-60. PubMed ID: 22215652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a novel selective PPARgamma modulator from (-)-Cercosporamide derivatives.
    Furukawa A; Arita T; Satoh S; Wakabayashi K; Hayashi S; Matsui Y; Araki K; Kuroha M; Ohsumi J
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2095-8. PubMed ID: 20219371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats.
    Yang B; Brown KK; Chen L; Carrick KM; Clifton LG; McNulty JA; Winegar DA; Strum JC; Stimpson SA; Pahel GL
    BMC Pharmacol; 2004 Oct; 4():23. PubMed ID: 15491498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of DS-6930, a potent selective PPARγ modulator. Part I: Lead identification.
    Shinozuka T; Tsukada T; Fujii K; Tokumaru E; Shimada K; Onishi Y; Matsui Y; Wakimoto S; Kuroha M; Ogata T; Araki K; Ohsumi J; Sawamura R; Watanabe N; Yamamoto H; Fujimoto K; Tani Y; Mori M; Tanaka J
    Bioorg Med Chem; 2018 Oct; 26(18):5079-5098. PubMed ID: 30241907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
    Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
    Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective targeting of PPARγ by the natural product chelerythrine with a unique binding mode and improved antidiabetic potency.
    Zheng W; Qiu L; Wang R; Feng X; Han Y; Zhu Y; Chen D; Liu Y; Jin L; Li Y
    Sci Rep; 2015 Jul; 5():12222. PubMed ID: 26183621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARgamma agonists diminish serum VEGF elevation in diet-induced insulin resistant SD rats and ZDF rats.
    Yang B; Lin P; Carrick KM; McNulty JA; Clifton LG; Winegar DA; Strum JC; Stimpson SA; Pahel GL
    Biochem Biophys Res Commun; 2005 Aug; 334(1):176-82. PubMed ID: 15993383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based drug design of a novel family of PPARgamma partial agonists: virtual screening, X-ray crystallography, and in vitro/in vivo biological activities.
    Lu IL; Huang CF; Peng YH; Lin YT; Hsieh HP; Chen CT; Lien TW; Lee HJ; Mahindroo N; Prakash E; Yueh A; Chen HY; Goparaju CM; Chen X; Liao CC; Chao YS; Hsu JT; Wu SY
    J Med Chem; 2006 May; 49(9):2703-12. PubMed ID: 16640330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.